SENSEX 77414.92 ▼ (0.25%)
BSE BANKEX 59542.38 ▲ (0.36%)

ROOPA INDUSTRIES

BSE: 530991 28 Jun 2025
Healthcare
₹ 56
Roopa Industries Ltd. specializes in Pharmaceuticals within the Healthcare sector.

ROOPA INDUSTRIES - Share Price & Details

Market Cap
₹46.3
High /Low
115.0 / 47.3
Stock P/E
22.8
Book Value
₹22.2
Dividend Yield
0.0
ROCE
12.1
ROE
₹12.3
Face Value
10.0
PEG Ratio
0.56
EVEBITDA
₹11.7
Debt
33.3
CMP / FCF
-12.6
Debt to equity
₹1.9
NP Ann
2.03
High price all time
115.0
Piotroski score
₹5.0
Graham Number
35.9
No. Eq. Shares
0.79
Net CF
₹0.40
Net profit
2.03
Price to book value
2.65
Interest Coverage
₹1.96
Low price all time
2.31
Industry PE
32.7
Reserves
₹9.63
Free Cash Flow
₹-6.58

Price Chart


Volume Chart


Peer Comparison

Stock Total Income Net Profit Net Sales EPS Market Cap (in Cr) P/E
LOOKS HEALTH SERVICES LIMITEDNANANANA5.11256.0
Triochem Products Ltd.,NANANANA0
ROOPA INDUSTRIES LTD.NANANANA46.322.8
SHELTER PHARMA LIMITEDNANANANA45.96.34
Deccan Health Care LimitedNANANANA45.639.3

Peer Comparison Chart


About ROOPA INDUSTRIES

Roopa Industries Ltd., with Security Code 530991, is a leading player in the Pharmaceuticals industry, categorized under the Healthcare sector, offering Equity instruments.


Latest News

Roopa Industries Reports Mixed Financial Results Amidst Sales Growth and Profit Concerns in March 2025

(30 May 2025)
Roopa Industries has announced its financial results for the quarter ending March 2025, reporting net sales of Rs 60.56 crore,...
Read more →

Analysts Have Been Trimming Their Rupa & Company Limited (NSE:RUPA) Price Target After Its Latest Report

(28 May 2025)
It's been a good week for Rupa & Company Limited ( NSE:RUPA ) shareholders, because the company has just released its...
Read more →

Roopa Industries Adjusts Evaluation Amid Positive Sales Growth and High Debt Concerns

(14 May 2025)
Roopa Industries, a microcap in the Pharmaceuticals & Drugs sector, has adjusted its evaluation amid a shift in market conditions.
Read more →

Roopa Industries Faces Volatility Amidst Positive Sales Growth and Weak Fundamentals

(01 Apr 2025)
Roopa Industries, a microcap in the Pharmaceuticals & Drugs sector, hit a new 52-week low amid significant volatility.
Read more →

Roopa Industries Faces Volatility Amid Strong Sales Growth and Valuation Opportunities

(31 Mar 2025)
Roopa Industries, a microcap in the Pharmaceuticals & Drugs sector, has faced significant volatility, reaching a 52-week low. The company has underperformed...
Read more →

Roopa Industries Reports Sales Growth Amid Financial Health Concerns and Market Sentiment Shift

(15 Mar 2025)
Roopa Industries, a microcap in the Pharmaceuticals & Drugs sector, recently adjusted its evaluation amid mixed performance indicators. In Q3 FY24-25,...
Read more →